Anne Makipernaa

Dr. Anne Makipernaa


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2011 in Haemophilia
Verified
Journal Article
Closed access
PDF file
SRS. Ranta
S. Ranta
TKT. Kalajoki‐Helmiö
T. Kalajoki‐Helmiö
JPJ. Pouttu
J. Pouttu
AMAnne Makipernaa
Anne Makipernaa

20 April 2021 in Children
Verified
Journal Article
Open access
PDF file
JAJohanna Aronniemi
Johanna Aronniemi
SLSatu Långström
Satu Långström
KMKatariina A. Mattila
Katariina A. Mattila
AMAnne Makipernaa
Anne Makipernaa
PSPäivi Salminen
Päivi Salminen
RLRiitta Lassila
Riitta Lassila
Introduction: Venous malformations (VMs) are congenital low-flow lesions with a wide spectrum of clinical manifestations. An increasing number of studies link VMs to coagulation abnormalities, especially to elevated D-dimer and decreased fibrinogen. This condition, termed localized intravascular coagulopathy (LIC), may pose a risk for hemostatic complications. However, detailed data on the laboratory variables for coagulation and fibrinolytic activity in VM patients are limited. We addressed this question by systematically analyzing the coagulation parameters in pediatric VM patients. Methods: We included 62 patients (median age 11.9 years) with detailed laboratory tests for coagulation and fibrinolytic activity at a clinically steady phase. We assessed clinical and imaging features of VMs and their correlations with coagulation and fibrinolysis variables using patient records and MRI. Results: D-dimer was elevated in 39% and FXIII decreased in 20% of the patients, as a sign of LIC. Elevated D-dimer and decreased FXIII were associated with large size, deep location, and diffuse and multifocal VMs. FVIII was elevated in 17% of the patients and was associated with small VM size, superficial and confined location, discrete morphology, and less pain. Surprisingly, antithrombin was elevated in 55% of the patients but without associations with clinical or other laboratory variables. Conclusions: LIC was common in pediatric patients with VMs. Our results provide a basis for when evaluating the risks of hemostatic complications in children with VMs. Further research is warranted to explore the mechanisms behind coagulation disturbances and their relation to clinical complications.

26 September 2013 in European Archives of Paediatric Dentistry
Verified
Journal Article
Closed access
PDF file
HRH. Rajantie
H. Rajantie
HAH. Alapulli
H. Alapulli
AMAnne Makipernaa
Anne Makipernaa
SRS. Ranta
S. Ranta

30 May 2011 in Haemophilia
Verified
Journal Article
Closed access
PDF file
SRS. Ranta
S. Ranta
SKS. Koskinen
S. Koskinen
AMAnne Makipernaa
Anne Makipernaa

28 May 2012 in Haemophilia
Verified
Journal Article
Closed access
PDF file
SRS. Ranta
S. Ranta
BVB. Verbruggen
B. Verbruggen
AWA. Wikström
A. Wikström
AMAnne Makipernaa
Anne Makipernaa

1 May 2008 in Haemophilia
Verified
Journal Article
Closed access
PDF file
AMAnne Makipernaa
Anne Makipernaa
LBL. VON Bonsdorff
L. VON Bonsdorff